N
Navin Kumar Verma
Researcher at Nanyang Technological University
Publications - 111
Citations - 3769
Navin Kumar Verma is an academic researcher from Nanyang Technological University. The author has contributed to research in topics: Signal transduction & Antimicrobial. The author has an hindex of 29, co-authored 97 publications receiving 2870 citations. Previous affiliations of Navin Kumar Verma include Department of Biotechnology & University of British Columbia.
Papers
More filters
Journal ArticleDOI
Methods and strategies for the synthesis of diverse nanoparticles and their applications: a comprehensive overview
Chetna Dhand,Neeraj Dwivedi,Xian Jun Loh,Alice Ng Jie Ying,Navin Kumar Verma,Roger W. Beuerman,Rajamani Lakshminarayanan,Seeram Ramakrishna +7 more
TL;DR: A comprehensive overview on various physical, chemical and bio-assisted methods largely employed to synthesize and fabricate NPs of varying size, surface characteristics, functionalities and physicochemical behavior is provided in this paper.
Journal ArticleDOI
Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovani
Navin Kumar Verma,Chinmoy S. Dey +1 more
TL;DR: It is demonstrated that miltefosine induces apoptosis-like death in L. donovani based on observed phenomena such as nuclear DNA condensation, DNA fragmentation with accompanying ladder formation, and in situ labeling of DNA fragments by the terminal deoxyribonucleotidyltransferase-mediated dUTP-biotin nick end labeling method.
Journal ArticleDOI
Magnetic core-shell nanoparticles for drug delivery by nebulization
Navin Kumar Verma,Kieran Crosbie-Staunton,Amro Satti,Shane A. Gallagher,Katie B. Ryan,Timothy Doody,Colm McAtamney,Ronan MacLoughlin,Paul Galvin,Conor S. Burke,Yuri Volkov,Yurii K. Gun'ko +11 more
TL;DR: A magnetic core-shell nanoparticle-based nanocarrier system is developed and the feasibility of its drug delivery capability via aerosol administration is evaluated and has implications for targeted delivery of therapeutics and poorly soluble medicinal compounds via inhalation route.
Journal ArticleDOI
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Tammy Song,Maarja-Liisa Nairismagi,Yurike Laurensia,Jing Quan Lim,Jing Tan,Zhi Mei Li,Wan Lu Pang,Atish Kizhakeyil,Giovani Claresta Wijaya,Dachuan Huang,Sanjanaa Nagarajan,Burton Kuan Hui Chia,Daryl Ming Zhe Cheah,Yan Hui Liu,Fen Zhang,Hui Lan Rao,Tiffany Tang,Esther Kam Yin Wong,Jin Xin Bei,Jabed Iqbal,Jabed Iqbal,Nicholas Francis Grigoropoulos,Siok Bian Ng,Wee Joo Chng,Bin Tean Teh,Soo Yong Tan,Navin Kumar Verma,Hao Fan,Hao Fan,Soon Thye Lim,Choon Kiat Ong +30 more
TL;DR: It is demonstrated that STAT3 activation confers high PD-L1 expression, which may promote tumor immune evasion and the combination of PD-1/PD-L 1 antibodies and STAT3 inhibitors might be a promising therapeutic approach for NKTL, and possibly PTCL.
Journal ArticleDOI
Long-Term Real-Time In Vivo Drug Release Monitoring with AIE Thermogelling Polymer.
Sing Shy Liow,Qingqing Dou,Dan Kai,Zibiao Li,Sigit Sugiarto,Chris Y. Y. Yu,Ryan T. K. Kwok,Xiaohong Chen,Yun-Long Wu,Seow Theng Ong,Atish Kizhakeyil,Navin Kumar Verma,Ben Zhong Tang,Xian Jun Loh +13 more
TL;DR: In vivo drug release can be monitored precisely via a self-indicating drug delivery system consisting of a new aggregation-induced emission thermoresponsive hydrogel and a new drug concentration meter is developed.